Archive: 24/11/2014
High-dose interleukin-2 effective in mRCC pre-treated with VEGF-targeted therapies
High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated with VEGF-targeted agents, reveals research presented today at the ESMO Symposium on Immuno-Oncology in Geneva, Switzerland.
Nov 24, 2014
Psychology professor investigates how stress affects low-income Richmond-area parents' ability to raise children
Over the course of two years, Wendy Kliewer, Ph.D., a psychology professor at Virginia Commonwealth University, surveyed more than 300 low-income female caregivers who were parenting children in the Richmond area to learn ...
Nov 24, 2014